HOOKIPA Pharma Statistics
Share Statistics
HOOKIPA Pharma has 9.66M shares outstanding. The number of shares has increased by -88.16% in one year.
| Shares Outstanding | 9.66M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -71.31% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.19M |
| Failed to Deliver (FTD) Shares | 4.36K |
| FTD / Avg. Volume | 3.56% |
Short Selling Information
The latest short interest is 36.24K, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 36.24K |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.5% |
| Short Ratio (days to cover) | 1.08 |
Valuation Ratios
The PE ratio is -0.94 and the forward PE ratio is -0.66.
| PE Ratio | -0.94 |
| Forward PE | -0.66 |
| PS Ratio | 3.8 |
| Forward PS | 1.7 |
| PB Ratio | 0.85 |
| P/FCF Ratio | -1.24 |
| PEG Ratio | n/a |
Enterprise Valuation
HOOKIPA Pharma Inc. has an Enterprise Value (EV) of -33.97M.
| EV / Earnings | 0.42 |
| EV / Sales | -1.69 |
| EV / EBITDA | 0.44 |
| EV / EBIT | 0.35 |
| EV / FCF | 0.55 |
Financial Position
The company has a current ratio of 3.5, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.5 |
| Quick Ratio | 3.5 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 1.23 |
| Cash Flow / Debt | -51.36 |
| Interest Coverage | -308.18 |
Financial Efficiency
Return on equity (ROE) is -0.91% and return on capital (ROIC) is -101.78%.
| Return on Equity (ROE) | -0.91% |
| Return on Assets (ROA) | -0.51% |
| Return on Capital (ROIC) | -101.78% |
| Revenue Per Employee | 133.30K |
| Profits Per Employee | -540.26K |
| Employee Count | 151 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 368.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -73.24% in the last 52 weeks. The beta is 0.83, so HOOKIPA Pharma 's price volatility has been higher than the market average.
| Beta | 0.83 |
| 52-Week Price Change | -73.24% |
| 50-Day Moving Average | 2.54 |
| 200-Day Moving Average | 5.29 |
| Relative Strength Index (RSI) | 40.03 |
| Average Volume (20 Days) | 122.48K |
Income Statement
In the last 12 months, HOOKIPA Pharma had revenue of 20.13M and earned -81.58M in profits. Earnings per share was -8.63.
| Revenue | 20.13M |
| Gross Profit | 16.58M |
| Operating Income | -97.69M |
| Net Income | -81.58M |
| EBITDA | -77.34M |
| EBIT | -97.69M |
| Earnings Per Share (EPS) | -8.63 |
Balance Sheet
The company has 117.10M in cash and 6.56M in debt, giving a net cash position of 110.54M.
| Cash & Cash Equivalents | 117.10M |
| Total Debt | 6.56M |
| Net Cash | 110.54M |
| Retained Earnings | -369.26M |
| Total Assets | 109.73M |
| Working Capital | 64.59M |
Cash Flow
In the last 12 months, operating cash flow was -57.52M and capital expenditures -4.16M, giving a free cash flow of -61.68M.
| Operating Cash Flow | -57.52M |
| Capital Expenditures | -4.16M |
| Free Cash Flow | -61.68M |
| FCF Per Share | -6.53 |
Margins
Gross margin is 82.35%, with operating and profit margins of -485.34% and -405.29%.
| Gross Margin | 82.35% |
| Operating Margin | -485.34% |
| Pretax Margin | -403.46% |
| Profit Margin | -405.29% |
| EBITDA Margin | -384.24% |
| EBIT Margin | -485.34% |
| FCF Margin | -306.44% |
Dividends & Yields
HOOK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -463.98% |
| FCF Yield | -343.48% |
Analyst Forecast
The average price target for HOOK is $4.5, which is 141.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.5 |
| Price Target Difference | 141.9% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Jul 10, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 10, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -4.86 |
| Piotroski F-Score | 2 |